About FairJourney Biologics
FairJourney Biologics is a Healthcare company based in Porto (Portugal) founded in 2012 by Antonio Parada, and was acquired by Partners Group in July 2024. Provider of end to end antibody development services. FairJourney Biologics has completed 1 acquisition, including IONTAS. Its chief executive, as recorded, is Antonio Parada. Its website fjbio.com draws about 13 thousand monthly visits. FairJourney Biologics offers products and services including Antibody Discovery, Antibody Engineering, Protein Production, and Biophysical Characterization. Its focus areas include Biopharma Outsourcing, CDMO and Biologics.
Company details
FairJourney Biologics, established in 2012, excels in providing healthcare solutions, biopharma outsourcing, cdmo, and biologics. Provider of end to end antibody development services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Porto, Portugal
- Founders Antonio Parada
- Stage Acquired
- SectorsHealthcare
- Website fjbio.com
- Social LinkedIn YouTube
- Acquired by Partners Group (Jul 2024)
- Investors
- Investments & Acquisitions
- Acquired byPartners Group
(Jul 2024)
Products & Services of FairJourney Biologics
FairJourney Biologics offers a comprehensive portfolio of products and services, including Antibody Discovery, Antibody Engineering, Protein Production, and Biophysical Characterization.
Service for identifying antibodies using advanced libraries and displays.
Engineering antibodies for therapeutic and diagnostic applications.
Production of proteins for research and development purposes.
Analysis of antibody properties for optimal performance.
Apps and channels of FairJourney Biologics
its YouTube channel FairJourney Biologics has 459 subscribers and 30 videos.
Videos from FairJourney Biologics
The most watched videos on FairJourney Biologics's YouTube channel, FairJourney Biologics (459 subscribers). Click a video to play it here.
More on FairJourney Biologics.
Investors in FairJourney Biologics
FairJourney Biologics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Partners Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity funds are managed across multiple sectors globally. | 1996 | partnersgroup.com | Baar, Switzerland |
Investor details for FairJourney Biologics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of FairJourney Biologics
23 people are tracked at FairJourney Biologics (9 in leadership, 14 in team).
| Name | Role | Group |
|---|---|---|
Antonio Parada | Founder & CEO | Leadership |
Renata Pankiewicz | Head Of CLD Unit For Antibody Production | Leadership |
João Santos | Head Of Discovery And Engineering Unit I | Leadership |
João Paulo Alpendre | Head Of Logistics Division + New Ventures Unit | Leadership |
António Parada | Chief Executive Officer | Leadership |
Marc van Dijk | Chief Scientific Officer, Discovery And Engineering | Leadership |
Tatiana Resende | Head Of Discovery And Engineering Unit II | Leadership |
Brittany Jiang | Senior Research Scientist, Head Of Cell Biology | Leadership |
Fernando Martins | Head Of Discovery And Engineering Unit VI | Leadership |
Inês Castro | Associate Scientist II | Team |
Pedro Gomes | Senior Scientist | Team |
Ana Lima | Associate Scientist | Team |
Lígia Almeida | Senior Research Associate II | Team |
José Pereira | Senior Bioinformatician | Team |
Naomi Davidson | Associate Scientist | Team |
Dr. Shailja Dwivedi | Scientific Leader Early Process Development | Team |
André Real | Logistics Senior Technician | Team |
Cátia Pereira | Senior Scientist I | Team |
Ana Martins | Senior Research Associate II | Team |
Miguel Marques | Senior Research Associate II | Team |
3 more people are available in the full profile.
Complete people profiles for FairJourney Biologics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FairJourney Biologics
FairJourney Biologics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include IONTAS.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapeutic antibody discovery and development services are offered. | iontas.co.uk | Cambridge, United Kingdom | 2007 | May 2020 | •••• |
Complete acquisition details for FairJourney Biologics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of FairJourney Biologics
3 dated milestones of FairJourney Biologics across 12 years, from founding to its latest funding, stage changes and deals.
- Founded FairJourney Biologics is founded.
- Acquisition Acquires IONTAS.
- Exit Acquired by Partners Group.
Web traffic of FairJourney Biologics
The website of FairJourney Biologics (fjbio.com) receives about 12.7K visits a month.
- Monthly visits12.7K
▼ 8.6% vs previous month
Websites whose visitors overlap most with FairJourney Biologics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| adapttech.eu | 91% | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fairjourney Biologics
Complete news archive for FairJourney Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FairJourney Biologics
FairJourney Biologics was founded in 2012.
FairJourney Biologics is headquartered in Porto, Portugal.
Antonio Parada is the CEO of FairJourney Biologics, as recorded in our data. They have also founded this company.
FairJourney Biologics, established in 2012, excels in providing healthcare solutions, biopharma outsourcing, cdmo, and biologics. Provider of end to end antibody development services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
FairJourney Biologics offers Antibody Discovery, Antibody Engineering, Protein Production, and Biophysical Characterization.
FairJourney Biologics has made 1 acquisition, including IONTAS.
FairJourney Biologics has 1 investor. Key investors include Partners Group.
Yes. FairJourney Biologics was acquired by Partners Group in July 2024.